Molecular Diagnostics Market by Infectious Diseases and Technology - Global Industry Analysis and Forecast to 2022
Molecular Diagnostics Market from Qurate’s Repository provides detailed information, in-depth analysis, and forecast which is developed by a team of experts and professionals
(EMAILWIRE.COM, August 22, 2018 ) Industry Outlook and Trend Analysis
The Molecular Diagnostics Market was worth USD 2.50 billion in the year 2012 and is expected to reach approximately USD 6.05 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 9.24% during the forecast period. Molecular diagnostics are exceptionally viable in diagnosing contagious diseases and operating preventive cancer screening in this way assisting healthcare experts with prescribing precise restorative mediations in the beginning periods of sicknesses. Expanding pervasiveness of hospital procured diseases and other transferable contaminations are anticipated to drive the area extension over the conjecture time frame. Molecular diagnostics help in the early conclusion of contagious ailments, cancer, and other hereditary issue. Technological progressions play a crucial part in conveying quick and precise test outcomes. This is assessed to empower more noteworthy infiltration of molecular diagnostics in hospitals and additionally in point of care (PoC) facilities. As genetic varieties frame the base of different target diseases, the relentlessly developing reception of molecular diagnostics is foreseen to upgrade the acknowledgment level of customized molecular medicine over the estimate time frame.
Get Free Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54834
Technology Outlook and Trend Analysis
In 2015, the 46% of the total industry share was taken by PCR technology. Nevertheless, the revenue share is predicted to decrease owing to rise of several other technologies like in-situ hybridization and genetic sequencing over the forecast period. Developments in genomics and proteomics have attributed to rise of new diagnostic methods. Patient and physician awareness, growth of inventive diagnostic tests, pairing of tests with novel treatment methods and affordability, is anticipated to propel the growth of this market.
Infectious Diseases Outlook and Trend Analysis
The global molecular diagnostics based on different infectious diseases are segmented into Flu, Tuberculosis, Meningitis, RSV Virus, Hepatitis B, Hepatitis C, HPV, STD, HIV, Dengue, Gonorrhea, Chlamydia, TORCH, and H. Pylori. The test location fragment incorporates PoC, central laboratories, and self-test or over-the-counter. In 2015 Central laboratories commanded this fragment with a share of more than 60 percent. The major components adding to the expansive share of this portion are high method volumes, their bigger existence in the nations that are underdeveloped, and the rising consciousness about early detection of diseases. The PoC section is anticipated to indicate lucrative development in the upcoming years. Advent of technologically inventive gadgets and the rising requirement for bedside patient monitoring are the key drivers highlighting the development of this portion. For example, the cobas product array by Roche is a PCR-based PoC framework additionally assessed to furnish this section with an exponential development platform. In 2015, the reagents section held the biggest offer producing income of around USD 3.6 billion. The reagents segment is determined to develop at a significant pace, along these lines rendering it the quickest developing section. Besides, instruments fragment is relied upon to develop at a critical development rate inferable from the expanding R&D activities for biomarker revelation and improvement. Molecular diagnostics finds wide applications in different fields including diabetes, pharmacogenomics, neurological & cardiovascular diseases, oncology, infectious diseases, and genetic testing. In 2015 infectious diseases held the biggest piece of the pie of more than 45 percent ascribed to the existence of novel multiplex PCR tests to distinguish viral load and infectious organisms. Cancer represents a vast monetary weight in the developing and in addition developed economies. Set up players are implementing R&D attempts to create novel, biomarker-based companion analytic tests. F. Hoffmann-La Roche Ltd, Abbott, and bioMérieux SA got the United States Food and Drug Administration endorsement in 2014 for their companion diagnostics for cancer therapeutics.
Regional Outlook and Trend Analysis
North America held a major share of around 45 percent in 2015 and has turned out to be a standout amongst the most powerful markets in the molecular diagnostics market. Existence of entrenched laboratory accreditation system, positive awareness programs instructing patients about early detection and the growing expenditure of healthcare are the key factors strengthening the predominance of this area. Government administrative activities play a critical part in advancing PoC offices, which is foreseen to affect the segment as a solid driver. For example, in the United States, the advent of Clinical Laboratory Improvement Amendments confirmation has prompted an expanded utilization rate of PoC gadgets over the estimate time frame. In the course of recent years, creating countries including India and China have shown persistent advancement, which is anticipated to offer prospering chances to the molecular diagnostics sector. Developing external funding for clinical investigations in this district is expected to drive the vertical toward lucrative development. Neglected requirements and the rising aged populace are assessed to be key concentration zones of the real players in this vertical. For example, organizations like Insight Kindstar Globalgene Technology, Inc and Genetics are focusing on improvement of cancer care in the Peoples Republic of China.
Competitive Insights
Some of the leading players in the market are Novartis, Bayer, Becton Dickinson, Danaher Corporation, Roche Holding AG, Qiagen, Abbott Molecular Inc, Sysmex Corporation, Hologic, BioMerieux, Johnson & Johnson and Cepheid Inc.
Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54834
The global Molecular Diagnostics Market is segmented as follows-
By Product
Services & Software
Instruments
Reagents & Kits
By Technology
DNA Sequencing and Next-generation Sequencing
Polymerase Chain Reaction (PCR)
Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)]
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Other Technologies (Mass Spectrometry, Flow Cytometry, and Electrophoresis)
By Application
Genetic Tests
Microbiology
Infectious Diseases
Blood Screening
Oncology
Others
By Region
North America
U.S
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
Rest of the World
Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Get Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-54834
The Molecular Diagnostics Market was worth USD 2.50 billion in the year 2012 and is expected to reach approximately USD 6.05 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 9.24% during the forecast period. Molecular diagnostics are exceptionally viable in diagnosing contagious diseases and operating preventive cancer screening in this way assisting healthcare experts with prescribing precise restorative mediations in the beginning periods of sicknesses. Expanding pervasiveness of hospital procured diseases and other transferable contaminations are anticipated to drive the area extension over the conjecture time frame. Molecular diagnostics help in the early conclusion of contagious ailments, cancer, and other hereditary issue. Technological progressions play a crucial part in conveying quick and precise test outcomes. This is assessed to empower more noteworthy infiltration of molecular diagnostics in hospitals and additionally in point of care (PoC) facilities. As genetic varieties frame the base of different target diseases, the relentlessly developing reception of molecular diagnostics is foreseen to upgrade the acknowledgment level of customized molecular medicine over the estimate time frame.
Get Free Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54834
Technology Outlook and Trend Analysis
In 2015, the 46% of the total industry share was taken by PCR technology. Nevertheless, the revenue share is predicted to decrease owing to rise of several other technologies like in-situ hybridization and genetic sequencing over the forecast period. Developments in genomics and proteomics have attributed to rise of new diagnostic methods. Patient and physician awareness, growth of inventive diagnostic tests, pairing of tests with novel treatment methods and affordability, is anticipated to propel the growth of this market.
Infectious Diseases Outlook and Trend Analysis
The global molecular diagnostics based on different infectious diseases are segmented into Flu, Tuberculosis, Meningitis, RSV Virus, Hepatitis B, Hepatitis C, HPV, STD, HIV, Dengue, Gonorrhea, Chlamydia, TORCH, and H. Pylori. The test location fragment incorporates PoC, central laboratories, and self-test or over-the-counter. In 2015 Central laboratories commanded this fragment with a share of more than 60 percent. The major components adding to the expansive share of this portion are high method volumes, their bigger existence in the nations that are underdeveloped, and the rising consciousness about early detection of diseases. The PoC section is anticipated to indicate lucrative development in the upcoming years. Advent of technologically inventive gadgets and the rising requirement for bedside patient monitoring are the key drivers highlighting the development of this portion. For example, the cobas product array by Roche is a PCR-based PoC framework additionally assessed to furnish this section with an exponential development platform. In 2015, the reagents section held the biggest offer producing income of around USD 3.6 billion. The reagents segment is determined to develop at a significant pace, along these lines rendering it the quickest developing section. Besides, instruments fragment is relied upon to develop at a critical development rate inferable from the expanding R&D activities for biomarker revelation and improvement. Molecular diagnostics finds wide applications in different fields including diabetes, pharmacogenomics, neurological & cardiovascular diseases, oncology, infectious diseases, and genetic testing. In 2015 infectious diseases held the biggest piece of the pie of more than 45 percent ascribed to the existence of novel multiplex PCR tests to distinguish viral load and infectious organisms. Cancer represents a vast monetary weight in the developing and in addition developed economies. Set up players are implementing R&D attempts to create novel, biomarker-based companion analytic tests. F. Hoffmann-La Roche Ltd, Abbott, and bioMérieux SA got the United States Food and Drug Administration endorsement in 2014 for their companion diagnostics for cancer therapeutics.
Regional Outlook and Trend Analysis
North America held a major share of around 45 percent in 2015 and has turned out to be a standout amongst the most powerful markets in the molecular diagnostics market. Existence of entrenched laboratory accreditation system, positive awareness programs instructing patients about early detection and the growing expenditure of healthcare are the key factors strengthening the predominance of this area. Government administrative activities play a critical part in advancing PoC offices, which is foreseen to affect the segment as a solid driver. For example, in the United States, the advent of Clinical Laboratory Improvement Amendments confirmation has prompted an expanded utilization rate of PoC gadgets over the estimate time frame. In the course of recent years, creating countries including India and China have shown persistent advancement, which is anticipated to offer prospering chances to the molecular diagnostics sector. Developing external funding for clinical investigations in this district is expected to drive the vertical toward lucrative development. Neglected requirements and the rising aged populace are assessed to be key concentration zones of the real players in this vertical. For example, organizations like Insight Kindstar Globalgene Technology, Inc and Genetics are focusing on improvement of cancer care in the Peoples Republic of China.
Competitive Insights
Some of the leading players in the market are Novartis, Bayer, Becton Dickinson, Danaher Corporation, Roche Holding AG, Qiagen, Abbott Molecular Inc, Sysmex Corporation, Hologic, BioMerieux, Johnson & Johnson and Cepheid Inc.
Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54834
The global Molecular Diagnostics Market is segmented as follows-
By Product
Services & Software
Instruments
Reagents & Kits
By Technology
DNA Sequencing and Next-generation Sequencing
Polymerase Chain Reaction (PCR)
Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)]
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Other Technologies (Mass Spectrometry, Flow Cytometry, and Electrophoresis)
By Application
Genetic Tests
Microbiology
Infectious Diseases
Blood Screening
Oncology
Others
By Region
North America
U.S
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
Rest of the World
Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Get Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-54834
Contact Information:
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results